| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.250 | 31.340 | 63.027 | 61.333 | 62.724 | 89.472 | 93.947 | 107.084 | 129.362 |
| Total Income - EUR | - | 8.250 | 31.340 | 63.027 | 61.333 | 66.007 | 89.472 | 102.594 | 107.084 | 153.486 |
| Total Expenses - EUR | - | 6.877 | 24.537 | 55.838 | 54.721 | 60.591 | 86.917 | 91.980 | 83.581 | 117.390 |
| Gross Profit/Loss - EUR | - | 1.374 | 6.803 | 7.188 | 6.612 | 5.416 | 2.555 | 10.615 | 23.503 | 36.096 |
| Net Profit/Loss - EUR | - | 1.291 | 6.489 | 6.560 | 5.998 | 4.966 | 1.661 | 9.615 | 22.453 | 28.402 |
| Employees | - | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Elyssium Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.079 | 9.481 | 28.408 | 23.375 | 18.582 | 55.518 | 34.514 | 29.426 | 9.705 |
| Current Assets | - | 1.073 | 4.651 | 75.945 | 69.284 | 9.075 | 9.708 | 3.038 | 4.224 | 30.875 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 1.176 | 0 | 75 | 0 |
| Receivables | - | 0 | 0 | 66.481 | 60.768 | 0 | 0 | 0 | 0 | 22.114 |
| Cash | - | 1.073 | 4.651 | 9.464 | 8.516 | 9.075 | 8.533 | 3.038 | 4.150 | 8.762 |
| Shareholders Funds | - | 1.336 | 7.803 | 14.219 | 19.942 | 24.531 | 25.647 | 35.342 | 22.502 | 28.451 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 816 | 6.329 | 90.134 | 72.717 | 3.126 | 39.579 | 2.210 | 11.148 | 12.130 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Elyssium Medical Srl